CN100459986C - Chinese medicine composition for treating rheumatoid disease - Google Patents

Chinese medicine composition for treating rheumatoid disease Download PDF

Info

Publication number
CN100459986C
CN100459986C CNB2003101053794A CN200310105379A CN100459986C CN 100459986 C CN100459986 C CN 100459986C CN B2003101053794 A CNB2003101053794 A CN B2003101053794A CN 200310105379 A CN200310105379 A CN 200310105379A CN 100459986 C CN100459986 C CN 100459986C
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
weight portions
rheumatoid disease
weight portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2003101053794A
Other languages
Chinese (zh)
Other versions
CN1611248A (en
Inventor
蒋艳群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2003101053794A priority Critical patent/CN100459986C/en
Publication of CN1611248A publication Critical patent/CN1611248A/en
Application granted granted Critical
Publication of CN100459986C publication Critical patent/CN100459986C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to a Chinese medicine composition for radically curing rheumatoid disease. Said composition contains 35-45 weight portions of thunder god vine and 55-65 weight portions of lonicera stem and leaf, if the patient's condition is serious, in the composition 8.2-13.2 weight portions of moghania root, 30.7-45.7 weight portions of jiucengcao, 16.5-26.55 weight portions of mistletoe and 27.1-32 weight portions of cyathula root can be added. Said invented Chinese medicine composition can obtain notablet effect, and has not any toxic side effect.

Description

The rheumatoid Chinese medicine composition of a kind of treatment
Technical field
The present invention relates to the rheumatoid Chinese medicine composition of a kind of treatment.
Background technology
Rheumatoid disease many by wind, cold, damp etc. invade meridians, the numbness resistance is obstructed, introduce toadstool and cause.At present, China's Chinese and western medicine all has treatment to rheumatoid disease, but only control with medicine, medicine stops ailing recurrence, be difficult to radical cure, it is a kind of commonly encountered diseases, is again a kind of difficult disease, most of patients disables or lifelong pain, very big to people's livelihood harm, radical cure pertinacious disease rheumatoid is for the people remove difficulties and alleviate sufferings, have great social significance and social benefit, existing domestic traditional integrative therapy rheumatoid has adopted anti-inflammatory analgetics such as cortisone, Phenylbutazone, Radix Tripterygii Wilfordii tablet, Ying Taiqing, can not effect a radical cure, medical expenses are higher simultaneously, and the patient is difficult to bear its financial burden.
Summary of the invention
The purpose of this invention is to provide a kind of radical cure and treat rheumatoid Chinese medicine composition.
The rheumatoid Chinese medicine composition of a kind of treatment, it is made by following raw materials by weight proportions: Radix Tripterygii Wilfordii 35-45 weight portion, Caulis Lonicerae 55-65 weight portion.
Weigh as the state of an illness, wherein also add the medicine of following weight proportion: Radix Flemingiae Philippinensis 8.2-13.2 weight portion, Herba Clinopodii Polycephali 30.7-45.7 weight portion, Herba Taxilli 16.5-26.55 weight portion, Radix Cyathulae medicine 27.1-32 weight portion.
The rheumatoid Chinese medicine composition of described a kind of treatment is made by 10 Cray Tripterygium wilfordii and 15 gram Caulis Loniceraes.
Therapeutic Method of the present invention adopts traditional Chinese herbal medicine of China's uniqueness, has that medical expense is economized, its medicine and whole medical expense be traditional 25% less than it, and advantages such as drug resource is very abundant are arranged again.(1), obvious effective rate: pain disappears, and joint function recovery 82 examples account for 72.6%.(2), effective percentage: pain relief, function of joint improve 13 examples, account for 11.5%.(3), total effective rate: account for 84.1%.(4), contrast general integrative medicine therapy, effective percentage raising 35.4%.Medicine of the present invention is the therapy that adopts with pain analgesia and treating the poisonous disease with poisonous drugs simultaneously, does not promptly damage its health, can effect a radical cure rehabilitation again, no longer recurrence from now on, and the present invention was accumulated at clinical treatment 113 examples in 5 years, and its effect is remarkable, has no side effect.
The specific embodiment
The rheumatoid Chinese medicine composition of a kind of treatment of the present invention, embodiment 1: get raw material by following weight: Radix Tripterygii Wilfordii 35-45 weight portion, Caulis Lonicerae 55-65 weight portion then adds three bowls in water to medicament mixed, decocts into one bowl, then oral, day is obeyed potion, one day twice, one after each meal, take continuously about one month, can effect a radical cure rheumatoid disease effectively.
Embodiment 2: if state of an illness weight person in the raw material of embodiment 1, also can add Radix Flemingiae Philippinensis 8.2-13.2 weight portion, Herba Clinopodii Polycephali 30.7-45.7 weight portion, Herba Taxilli 16.5-26.5 weight portion, Radix Cyathulae 27.1-32 weight portion, then medicament mixed is added three bowls in water, decoct into one bowl, then oral, day clothes potion, twice on the one, one after each meal is taken about one month continuously, can effect a radical cure rheumatoid disease effectively.
Embodiment 3: get raw material by following weight: Radix Tripterygii Wilfordii 10 grams, and Caulis Lonicerae 15 grams for once decocting oral consumption, then add three bowls in water to medicament mixed, decoct into one bowl, then oral, day clothes potion, twice on the one, one after each meal is taken about one month continuously, can effect a radical cure rheumatoid disease effectively.
Embodiment 4: if state of an illness weight person in the raw material of embodiment 3, also can add Radix Flemingiae Philippinensis 3 grams, Herba Clinopodii Polycephali 9 grams, Herba Taxilli 6 grams, Radix Cyathulae 7 grams, then medicament mixed is added three bowls in water, decoct into one bowl, then oral, day clothes potion, twice on the one, one after each meal is taken about one month continuously, can effect a radical cure rheumatoid disease effectively.
In order to strengthen the effect of Drug therapy, period in a medicine, can tie electrotherapy hot compress patient's joint and acupuncture point, perhaps in conjunction with massaging, massaging and press patient's periosteum and acupuncture point with qigong tact skill makes and tightened by muscle or the joint of atrophy loosens levelling, make unimpeded by the acupuncture point meridian of rheumatoid toxin numbness resistance, metabolism recovers, get rid of toxin.Because of stimulating the central nervous system, promote the comprehensive function curative effect simultaneously with maneuver.

Claims (2)

1. the rheumatoid Chinese medicine composition of treatment is characterized in that it is made by following raw materials by weight proportions: Radix Tripterygii Wilfordii 35-45 weight portion, Caulis Lonicerae 55-65 weight portion.
2. the rheumatoid Chinese medicine composition of treatment is characterized in that it is made by following raw materials by weight proportions: Radix Tripterygii Wilfordii 10 grams, Caulis Lonicerae 15 grams.
CNB2003101053794A 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease Expired - Fee Related CN100459986C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2003101053794A CN100459986C (en) 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2003101053794A CN100459986C (en) 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease

Publications (2)

Publication Number Publication Date
CN1611248A CN1611248A (en) 2005-05-04
CN100459986C true CN100459986C (en) 2009-02-11

Family

ID=34757280

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2003101053794A Expired - Fee Related CN100459986C (en) 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease

Country Status (1)

Country Link
CN (1) CN100459986C (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1307893A (en) * 2001-02-02 2001-08-15 郑春雷 Capsule and its production process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1307893A (en) * 2001-02-02 2001-08-15 郑春雷 Capsule and its production process

Also Published As

Publication number Publication date
CN1611248A (en) 2005-05-04

Similar Documents

Publication Publication Date Title
CN100998656A (en) Medicated wine for tonifying bone and removing obstruction in channels
CN101152354A (en) Traditional Chinese medicine for treating acute dacryocystitis
CN102475868A (en) Anti-rheumatism medicinal liquor
CN101940739A (en) Traditional Chinese medicine for treating gout
CN101721651B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN101138613A (en) Chinese traditional medicine for treating acute bronchitis of children
CN100411648C (en) Medicine for treating atrophic arthritis
CN102949619A (en) Traditional Chinese medicine composition for treating colitis
CN104162088A (en) Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof
CN100459986C (en) Chinese medicine composition for treating rheumatoid disease
CN103550446B (en) Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition
CN100998719B (en) Oral traditional Chinese medicine for treating amenorrhea of stagnancy qi and blood stasis type
CN101195006B (en) Exterior applying medicament for treating toothache due to pathogenic wind-fire
CN101143199A (en) Traditional Chinese medicine for treating chronic bronchitis
CN101129742A (en) Traditional Chinese medicine for treating rheumatoid arthritis in active stage
CN103494939A (en) Traditional Chinese medicine for treating senile habitual constipation
CN101596297B (en) Tinea-curing pill
CN102743487B (en) Traditional Chinese medicine for treating wet cold invasion type rheumatic aching muscles
CN102949653B (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN102526544B (en) Oral powder Chinese medicine formula for treating lumbar disc herniation and osteoproliferation
CN102218105A (en) Medicinal liquor for treating psoriasis and method for producing same
CN101259196B (en) Chinese medicinal composition for treating gastric ulcer
CN101143183A (en) Traditional Chinese medicine for treating intractable headache
CN101134098A (en) Traditional Chinese medicine for treating biliary ascariasis
CN1317028C (en) Recipe of navel plaster for treating enteritis quickly

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090211

Termination date: 20151030

EXPY Termination of patent right or utility model